These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35436165)

  • 1. Proteomic approaches for untangling pharmacological targets in acute myelogenous leukemia.
    Reikvam H; Hemsing AL; Hernandez-Valladares M; Birkeland E
    Expert Rev Proteomics; 2022 Feb; 19(2):73-76. PubMed ID: 35436165
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteomics in acute myelogenous leukaemia (AML): methodological strategies and identification of protein targets for novel antileukaemic therapy.
    Sjøholt G; Anensen N; Wergeland L; Mc Cormack E; Bruserud Ø; Gjertsen BT
    Curr Drug Targets; 2005 Sep; 6(6):631-46. PubMed ID: 16178797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy in acute myeloid leukemia: current status and new insights from a proteomic perspective.
    van Dijk AD; de Bont ESJM; Kornblau SM
    Expert Rev Proteomics; 2020 Jan; 17(1):1-10. PubMed ID: 31945303
    [No Abstract]   [Full Text] [Related]  

  • 4. Construction of protein profile classification model and screening of proteomic signature of acute leukemia.
    Xu Y; Zhuo J; Duan Y; Shi B; Chen X; Zhang X; Xiao L; Lou J; Huang R; Zhang Q; Du X; Li M; Wang D; Shi D
    Int J Clin Exp Pathol; 2014; 7(9):5569-81. PubMed ID: 25337199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse phase protein arrays in acute leukemia: investigative and methodological challenges.
    Hoff FW; Horton TM; Kornblau SM
    Expert Rev Proteomics; 2021 Dec; 18(12):1087-1097. PubMed ID: 34965151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.
    Tibes R; Qiu Y; Lu Y; Hennessy B; Andreeff M; Mills GB; Kornblau SM
    Mol Cancer Ther; 2006 Oct; 5(10):2512-21. PubMed ID: 17041095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia.
    Hu CW; Qiu Y; Ligeralde A; Raybon AY; Yoo SY; Coombes KR; Qutub AA; Kornblau SM
    Nat Biomed Eng; 2019 Nov; 3(11):889-901. PubMed ID: 30988472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemia.
    van Dijk AD; Hoff FW; Qiu YH; Chandra J; Jabbour E; de Bont ESJM; Horton TM; Kornblau SM
    Clin Epigenetics; 2021 Jan; 13(1):21. PubMed ID: 33509276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proteogenomic subtypes of acute myeloid leukemia.
    Jayavelu AK; Wolf S; Buettner F; Alexe G; Häupl B; Comoglio F; Schneider C; Doebele C; Fuhrmann DC; Wagner S; Donato E; Andresen C; Wilke AC; Zindel A; Jahn D; Splettstoesser B; Plessmann U; Münch S; Abou-El-Ardat K; Makowka P; Acker F; Enssle JC; Cremer A; Schnütgen F; Kurrle N; Chapuy B; Löber J; Hartmann S; Wild PJ; Wittig I; Hübschmann D; Kaderali L; Cox J; Brüne B; Röllig C; Thiede C; Steffen B; Bornhäuser M; Trumpp A; Urlaub H; Stegmaier K; Serve H; Mann M; Oellerich T
    Cancer Cell; 2022 Mar; 40(3):301-317.e12. PubMed ID: 35245447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives of proteomics in acute myeloid leukemia.
    Czibere A; Grall F; Aivado M
    Expert Rev Anticancer Ther; 2006 Nov; 6(11):1663-75. PubMed ID: 17134369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse phase protein array profiling reveals distinct proteomic signatures associated with chronic myeloid leukemia progression and with chronic phase in the CD34-positive compartment.
    Quintás-Cardama A; Qiu YH; Post SM; Zhang Y; Creighton CJ; Cortes J; Kornblau SM
    Cancer; 2012 Nov; 118(21):5283-92. PubMed ID: 22517119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New treatment for acute myelogenous leukemia.
    DiNardo CD; Cortes JE
    Expert Opin Pharmacother; 2015 Jan; 16(1):95-106. PubMed ID: 25480777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network analysis of reverse phase protein expression data: characterizing protein signatures in acute myeloid leukemia cytogenetic categories t(8;21) and inv(16).
    York H; Kornblau SM; Qutub AA
    Proteomics; 2012 Jul; 12(13):2084-93. PubMed ID: 22623292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative proteomic analysis of EZH2 inhibition in acute myeloid leukemia reveals the targets and pathways that precede the induction of cell death.
    Sandow JJ; Infusini G; Holik AZ; Brumatti G; Averink TV; Ekert PG; Webb AI
    Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28447382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of genetic targets on cancer therapy in acute myelogenous leukemia.
    Shah MV; Barochia A; Loughran TP
    Adv Exp Med Biol; 2013; 779():405-37. PubMed ID: 23288651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical detection of quantitative protein biomarkers provides insights into signaling networks deregulated in acute myeloid leukemia.
    Elo LL; Karjalainen R; Ohman T; Hintsanen P; Nyman TA; Heckman CA; Aittokallio T
    Proteomics; 2014 Nov; 14(21-22):2443-53. PubMed ID: 25211154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized medicine for acute myelogenous leukemia--at the entrance gate.
    Swords RT; Dezube BJ; Medeiros BC
    Am J Hematol; 2011 Aug; 86(8):631-2. PubMed ID: 21761430
    [No Abstract]   [Full Text] [Related]  

  • 18. Proteomic and genetic approaches identify Syk as an AML target.
    Hahn CK; Berchuck JE; Ross KN; Kakoza RM; Clauser K; Schinzel AC; Ross L; Galinsky I; Davis TN; Silver SJ; Root DE; Stone RM; DeAngelo DJ; Carroll M; Hahn WC; Carr SA; Golub TR; Kung AL; Stegmaier K
    Cancer Cell; 2009 Oct; 16(4):281-94. PubMed ID: 19800574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomic study of human myeloid leukemia cells differentiation to macrophages using DNA array, proteomic, and bioinformatic analytical methods.
    Juan HF; Lin JY; Chang WH; Wu CY; Pan TL; Tseng MJ; Khoo KH; Chen ST
    Electrophoresis; 2002 Aug; 23(15):2490-504. PubMed ID: 12210208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of proteomics between acute myeloid leukemia and acute lymphoid leukemia].
    Xiao P; Zeng YY; Nie YF; Lin W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1353-6. PubMed ID: 22169282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.